Tweet
Fars News Agency, Iran
Sept 19 2010
Iran Exports MS Drug to Syria, Armenia
TEHRAN (FNA)- The Iranian Health Ministry announced on Sunday that the
country has started exporting its recently produced MS drugs to some
foreign states, including Syria and Armenia.
"The Iran-made MS drug which was produced four years ago has now been
approved in the international scientific circles and entered the
export arena," Director-General of the Iranian Health Ministry for
Medication Mohammad Reza Shanehsaz told FNA, adding that the drug is
currently exported to Syria and Armenia.
Shanehsaz also announced that other countries have also demanded to
import Iran-made MS drugs as well as other Iranian medications.
Due to the high quality of Iran-made medicines and their
cost-effectiveness, the country will be turned into one of the most
important exporters of medicines in the region, he added.
Iran introduced two home-made MS drugs, namely Resigene (interferon
beta 1a) and Cinnovex, in the last few years.
Also, a well-known Iranian company started mass production of a third
Iran-made MS medication under the generic name of 'Ziferon' on
Saturday.
Interferon beta 1, generically known as Ziferon, is mainly injected
subcutaneously and has antiviral and immunomodulating properties. The
drug is mainly used in the management of multiple sclerosis, although
its mode of action is unclear.
The Center for Pharmaceutical Products has already produced five
biotechnological drugs, making Ziferon the sixth medication produced
by the company.
From: A. Papazian
Sept 19 2010
Iran Exports MS Drug to Syria, Armenia
TEHRAN (FNA)- The Iranian Health Ministry announced on Sunday that the
country has started exporting its recently produced MS drugs to some
foreign states, including Syria and Armenia.
"The Iran-made MS drug which was produced four years ago has now been
approved in the international scientific circles and entered the
export arena," Director-General of the Iranian Health Ministry for
Medication Mohammad Reza Shanehsaz told FNA, adding that the drug is
currently exported to Syria and Armenia.
Shanehsaz also announced that other countries have also demanded to
import Iran-made MS drugs as well as other Iranian medications.
Due to the high quality of Iran-made medicines and their
cost-effectiveness, the country will be turned into one of the most
important exporters of medicines in the region, he added.
Iran introduced two home-made MS drugs, namely Resigene (interferon
beta 1a) and Cinnovex, in the last few years.
Also, a well-known Iranian company started mass production of a third
Iran-made MS medication under the generic name of 'Ziferon' on
Saturday.
Interferon beta 1, generically known as Ziferon, is mainly injected
subcutaneously and has antiviral and immunomodulating properties. The
drug is mainly used in the management of multiple sclerosis, although
its mode of action is unclear.
The Center for Pharmaceutical Products has already produced five
biotechnological drugs, making Ziferon the sixth medication produced
by the company.
From: A. Papazian